Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial

By afschroeder • March 26, 2026

Hainstock MR, Fleming G, Kim D, Aboulhosn J, Levi D, Krasuski R, Sommer R, Torres AJ, Gray R, Kereiakes D, Leventhal A, Gillespie M, Szeto W, Zajarias A, Shahanavaz S, Steinberg ZL, Jones TK, Mahadevan VS, Moore P, Elmariah S, Shirali G, Li W, Babaliaros V, Lim DS; COMPASSION 3 Trial Executive Committee and Study Investigators. Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial. Circ Cardiovasc Interv. 2026 Mar 26:e016361. doi: 10.1161/CIRCINTERVENTIONS.125.016361. Epub ahead of print. PMID: 41884901.

Tags: Cardiology/Epi, endocarditis, Hemodynamics, Publications, pulmonary valve insufficiency, pulmonary valve stenosis, stents

Understanding Cardiac Anatomy and Imaging to Improve Safety of Procedures: The Right Ventricular Outflow Tract, Part 1

Miyazaki Y, Rimmer M, Hanna P, Park YM, Miyazaki K, Yamagami S, Shivkumar K, Mori S. Understanding Cardiac Anatomy and Imaging to Improve Safety of[...]

Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial

McDonald CM, Villa C, Soslow JH, Maharry K, Hogan N, Binks M, Berth KC, Elliott KA, Taylor M, Hor KN, Signorovich J, Henricson EK, Phan[...]

National Midterm Outcomes of Ex-Vivo Heart Perfusion in Heart Transplantation

Song J, Cho PD, Zappacosta H, White JP, McKay S, Daniel M, Abramov A, Girish A, Telesca D, Husain M, Ardehali A. National Midterm Outcomes[...]